Dr. Sladek is a member of the Firm's Intellectual Property Group and practices as a patent lawyer. His focus is drafting and prosecuting patent applications in the biotechnology space.
Prior to establishing his private practice, Dr. Sladek worked as a patent lawyer at pharmaceutical, biotechnology and animal health companies for 15 years. In those industries, he worked with scientists and manager teams to develop strategic intellectual property solutions for pipeline R&D projects, as well as life-cycle management solutions for existing products. He is especially proficient in working with inventors and project leads to draft patent applications that protect their inventive concepts and provide freedom-to-operate in the marketplace. He prosecutes those applications to efficiently obtain allowances.
Dr. Sladek has drafted and/or prosecuted patent applications related to enzymes, microbes, biological formulations, microbiology methods, fermentation technologies, human and veterinary vaccines, vaccine adjuvants, viral expression vectors, monoclonal antibodies, transcriptomic methods, non-dairy foods and others.
Before attending law school, Dr. Sladek was a professor in the microbiology department of a medical school, directing a small biomedical research laboratory and teaching medical and graduate students. He is trained as a virologist, molecular biologist and cancer cell biologist, and he has laboratory experience in bacteriology, mammalian cell culture, viral vectors, flow cytometry and cell staining, embryonic stem cells and transgenic animal models. He has more than 20 scientific publications.